Tests omega-3 fatty acids in youth with autism spectrum disorder
Tests omega-3 supplements against a placebo in children and teens with autism.
Plain-language title generated from the registry record
Registry title: Omega-3, Autism Spectrum Disorder (ASD)
Key facts
- Where
- Taichung, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 17 years old?
Source: NCT07365553, who can take part
Where in Taiwan
- China Medical UniversityTaichung, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- China Medical University Hospital
- Trial code
- NCT07365553
- Record updated
- 26 January 2026
- Original description
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).Read full original descriptionShow less
Omega-3 Fatty Acids and Autism Spectrum Disorder (ASD) - A Double-blind Randomized Controlled Trial of Omega-3 Fatty Acids in Youth With ASD
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Inclusion: diagnosis of DSM5 ASD made by child and adolescent psychiatrist; age 6-17 years-old at the time of enrolment; no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks,; Signed informed consent.
Exclusion: currently using omega-3 supplements or probiotics; comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder; comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders; allergy to omega-3.